KASSBERG THOMAS RICHARD (CBO & EVP) sold 13.9% of their position (39.88K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $1.31M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/24/2023ACC: 0001209191-23-053487
Officer· CBO & EVP
Since Mar 2019
-39.88K
Net shares
Net seller
$1.31M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
39.88K acquired · 79.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+39.88K
Price / share
$6.86
Trade value
$273.56K
% of position
16.2%
10/23/2023
246.86K→286.74K
Common Stock
Direct
Shares
−39.88K
Price / share
$32.78
Trade value
$1.31M
% of position
13.9%
10/23/2023
286.74K→246.86K
Total
Net shares
+0.00
Net value
-$1.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/23/2023 | M · Option Exercise | +39.88K | $6.86 | $273.56K | 16.2% | 246.86K | 286.74K |
| Common Stock Direct | 10/23/2023 | S · Sale | −39.88K | $32.78 | $1.31M | 13.9% | 286.74K | 246.86K |
| Total | +0.00 | -$1.03M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
39.88K shares
Shares
−39.88K
Strike price
6.86
Held after
0.00
Exercisable
—
10/23/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock39.88K shares | 10/23/2023 | M · Option Exercise | −39.88K | 6.86 | — | 0.00 |